Stemline Therapeutics to Present at the Jefferies 2013 Global Healthcare Conference

        Print
| Source: Stemline Therapeutics, Inc.

NEW YORK, May 31, 2013 (GLOBE NEWSWIRE) -- Stemline Therapeutics, Inc. (Nasdaq:STML) announced today that Ivan Bergstein, M.D., Chief Executive Officer, will present at the Jefferies 2013 Global Healthcare Conference on Thursday, June 6, 2013 at 9 am ET. The conference will take place at the Grand Hyatt in New York, NY. A live webcast and 30-day archive of the event can be viewed at the Company's website at www.stemline.com.

About Stemline:

Stemline Therapeutics, Inc. is a clinical-stage biopharmaceutical company developing novel oncology therapeutics that target both cancer stem cells (CSCs) as well as the tumor bulk. Stemline's clinical candidates, SL-401 and SL-701, have demonstrated clinical activity, including durable complete responses (CRs), in Phase 1/2 studies of patients with advanced hematological and brain cancer, respectively. For more information about Stemline Therapeutics, visit www.stemline.com.

Stemline Contact:

Mark Jacobson
Director, Corporate Development
Stemline Therapeutics, Inc.
750 Lexington Avenue
Sixth Floor
New York, NY 10022
Tel: 646-502-2307
Email: